Loading...

Boston Scientific Corporation

BSX-PANYSE
Healthcare
Medical - Devices
$122.18
$2.83(2.37%)

Boston Scientific Corporation BSX-PA Peers

See (BSX-PA) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Devices Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
BSX-PA$122.18+2.37%175.4B230.53$0.53N/A
ABT$125.73+1.05%218.7B15.79$7.96+1.86%
BSX$103.16-0.60%152.6B75.31$1.37N/A
SYK$395.15+2.02%151.1B53.42$7.40+0.84%
MDT$91.65+2.17%117.4B25.39$3.61+3.07%
EW$76.30-0.33%44.8B31.53$2.42N/A
DXCM$85.12+1.30%33.4B64.00$1.33N/A
PHG$25.02+1.96%23.1B83.37$0.30+3.55%
STE$223.69+0.47%22B36.30$6.16+1.02%
PODD$285.57+1.64%20.1B52.02$5.49N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

BSX-PA vs ABT Comparison

BSX-PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BSX-PA stands at 175.4B. In comparison, ABT has a market cap of 218.7B. Regarding current trading prices, BSX-PA is priced at $122.18, while ABT trades at $125.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BSX-PA currently has a P/E ratio of 230.53, whereas ABT's P/E ratio is 15.79. In terms of profitability, BSX-PA's ROE is +0.10%, compared to ABT's ROE of +0.32%. Regarding short-term risk, BSX-PA is more volatile compared to ABT. This indicates potentially higher risk in terms of short-term price fluctuations for BSX-PA.

Stock Price Comparison

Loading...

Frequently Asked Questions

;